Organization profile

Organization profile

The Division of Arthritis and Rheumatic Diseases at Oregon Health & Science University is a group of academic physicians, allied health professionals and nurse practitioners specializing in the diagnosis and treatment of the full spectrum of rheumatic disorders.

Fingerprint The fingerprint is based on mining the text of the scientific documents related to the associated persons. Based on that an index of weighted terms is created, which defines the key subjects of research unit

Ankylosing Spondylitis Medicine & Life Sciences
Psoriatic Arthritis Medicine & Life Sciences
Rheumatoid Arthritis Medicine & Life Sciences
Placebos Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Tumor Necrosis Factor-alpha Medicine & Life Sciences
Inflammation Medicine & Life Sciences
T-Lymphocytes Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.


No photo of Mark Asquith

Mark Asquith

Person: Academic

No photo of Michael Davey

Projects 1978 2019

Regeneration of hyaline cartilage in situ with bone marrow mesenchymal stem cells

Chu, C.

National Institutes of Health


Project: Research projectNon-HHS Research Projects

Hyaline Cartilage
Mesenchymal Stromal Cells
Bone Marrow

Positive and Negative Regulation of IL-17 in Experimental Arthritis

Chu, C.

National Institutes of Health


Project: Research projectClinical Investigator Award (CIA)

Experimental Arthritis
Th17 Cells

Research Output 1991 2019

2 Citations

Three Multicenter, Randomized, Double-Blind, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Ustekinumab in Axial Spondyloarthritis

Deodhar, A. A., Gensler, L. S., Sieper, J., Clark, M., Calderon, C., Wang, Y., Zhou, Y., Leu, J. H., Campbell, K., Sweet, K., Harrison, D. D., Hsia, E. C. & van der Heijde, D., Jan 1 2019, (Accepted/In press) In : Arthritis and Rheumatology.

Research output: Contribution to journalArticle

Tumor Necrosis Factor-alpha
1 Citations

4-year results from the RAPID-PsA phase 3 randomised placebo-controlled trial of certolizumab pegol in psoriatic arthritis

Van Der Heijde, D., Deodhar, A. A., Fitzgerald, O., Fleischmann, R., Gladman, D., Gottlieb, A. B., Hoepken, B., Bauer, L., Irvin-Sellers, O., Khraishi, M., Peterson, L., Turkiewicz, A., Wollenhaupt, J. & Mease, P. J., Jan 1 2018, In : RMD Open. 4, 1, e000582.

Research output: Contribution to journalArticle

Psoriatic Arthritis
Randomized Controlled Trials

Advances in spondyloarthritis: Glimpse in the future

Deodhar, A. A., Jul 1 2018, In : Current Opinion in Rheumatology. 30, 4, p. 301-302 2 p.

Research output: Contribution to journalEditorial